Archive for Profitability

By Dr Philip Koopowitz – Director Dispex The Hayfever season is well and truly upon us. This month we look at the current common treatments’ available for runny noses, sneezing...

Boost Your Dispensary’s Profitability with Dispex Online Tools Are you making the most of the tools available to support dispensary profitability? If not, now’s the perfect time to explore two...

By Dr Philip Koopowitz – Director Dispex Part 2 of 3 -Making sense of Vitamin D prescribing for primary prevention and maintenance dose treatment. Many dispensaries have a range of...

By Dr Philip Koopowitz – Director Dispex The Hayfever season is well and truly upon us. This month we look at the current common treatments’ available for runny noses, sneezing...

Each month over 80 commonly dispensed generics, as priced in the Drug Tariff or DM+D, are priced at a lower price than the purchase price. When you take the clawback...

We understand that one of the biggest challenges clinicians face is navigating the nuances of when to prescribe generically versus by brand—and if by brand, which one is the most...

One of the biggest challenges in dispensary-friendly prescribing is navigating the nuances involved, but we’ve got you covered- introducing the Dispex Nudger! This smart pop-up alerts you when a more...

Update From 3rd February the reimbursement price of Staladex (Leuprorelin 11.25mg implant pre-filled syringes) decreased from £208.79 to £206.00. To see how this has affected profitability click on this link...

One of the biggest challenges in dispensary-friendly prescribing is navigating the nuances involved, but we’ve got you covered- introducing the Dispex Nudger! This smart pop-up alerts you when a more...

5 changes to January  2025  Drug Tariff 5.5 additions to January  2025 Drug Tariff Members click here to login.  

Dispensary Friendly Formularies Using the Brand Comparisons data from the Dispex website, we will be publishing dispensary friendly formularies for a number of conditions. Members can click here to view...